A Novel Dysferlin‐Binding Kinase CK2α Promotes Plasma Membrane Repair in Dysferlinopathy
The FASEB Journal · 31.03.2026 · 40 (6)
DOI: 10.1096/fj.202500773rrr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 13.03.2026. Verfasst von Naoko Nakamura und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Tohoku University School of Medicine, Sendai, Miyagi, Japan. Hauptthemen laut MEDLINE: Dysferlin, Cell Membrane, Casein Kinase II, Muscular Dystrophies, Limb-Girdle. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS), Ministry of Health, Labour and Welfare (MHLW), National Center of Neurology and Psychiatry (NCNP).
Abstract (Originalsprache)
Dysferlinopathy is an adult‐onset form of muscular dystrophy caused by mutations in the dysferlin gene and is inherited in an autosomal recessive manner. Dysferlin is primarily known for its role in plasma membrane repair. Although several proteins associated with dysferlin have been identified, many aspects of its signaling pathways and protein–protein interactions remain unclear. Here, we focused on the region between the third and fourth C2 domains, where frequent genetic mutations occur and functional domains are concentrated, and identified the protein kinase CK2α (formerly known as casein kinase 2) as a novel dysferlin‐binding protein. CK2α was found to accumulate at membrane injury sites along with dysferlin in mouse skeletal muscle, and membrane repair was delayed in CK2α knockout cells. Furthermore, overexpression of CK2α in dysferlin‐deficient mouse muscle led to improved membrane repair. Additionally, we revealed that CK2α plays a role in phosphorylating annexin A1, which is known to bind to dysferlin and is involved in plasma membrane repair. Our results indicated that CK2α controls membrane repair by participating in the phosphorylation of annexin A1. The molecular interplay among dysferlin, CK2α, and phosphorylated annexin A1 represents a novel therapeutic target for promoting membrane repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Tohoku University School of Medicine, Sendai, Miyagi, Japan.
- Department of Rehabilitation Medicine, Tohoku University School of Medicine, Sendai, Miyagi, Japan.
- The Institute of Development, Aging and Cancer, Tohoku University, Sendai, Miyagi, Japan.
- Institute of Basic Medical Research, International University of Health and Welfare, Narita, Chiba, Japan.
- National Hospital Organization Iwate National Hospital, Ichinoseki, Iwate, Japan.
- Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.
ORCID-Profile: Naoko Nakamura, Naoki Suzuki, Shin-Ichiro Kanno, Hiroya Ono, Rumiko Izumi, Rui Muliang, Christian Borgo, Akiyuki Ohno, Ryuhei Harada, Kensuke Ikeda, Shio Mitsuzawa, Yasuaki Watanabe, Tomomi Shijo, Tetsuya Akiyama, Toshiaki Takahashi, Makoto Kanzaki, Shion Osana, Hitoshi Warita, Yoshitsugu Aoki, Satoru Ebihara, Mauro Salvi, Ryoichi Nagatomi, Akira Yasui, Katsuya Miyake, Masashi Aoki
Förderung
- MEXT | Japan Society for the Promotion of Science (JSPS)
- Ministry of Health, Labour and Welfare (MHLW)
- National Center of Neurology and Psychiatry (NCNP)
- Japan Society for the Promotion of Science
Zitieren
APA
Nakamura, N., Suzuki, N., Kanno, S. I., Yamanaka, R., Ono, H., Izumi, R., Muliang, R., Borgo, C., Ohno, A., Harada, R., Saito, S., Funayama, Y., Ikeda, K., Mitsuzawa, S., Watanabe, Y., Shijo, T., Akiyama, T., Takahashi, T., Kanzaki, M., …, & Aoki, M. (2026). A Novel Dysferlin‐Binding Kinase CK2α Promotes Plasma Membrane Repair in Dysferlinopathy. The FASEB Journal, 40(6). https://doi.org/10.1096/fj.202500773rrr
Vancouver
Nakamura N, Suzuki N, Kanno SI, Yamanaka R, Ono H, Izumi R, et al. A Novel Dysferlin‐Binding Kinase CK2α Promotes Plasma Membrane Repair in Dysferlinopathy. The FASEB Journal. 2026;40(6). doi:10.1096/fj.202500773rrr
BibTeX
@article{Nakamura2026,
author = {Nakamura, Naoko and Suzuki, Naoki and Kanno, Shin-Ichiro and Yamanaka, Rei and Ono, Hiroya and Izumi, Rumiko and Muliang, Rui and Borgo, Christian and Ohno, Akiyuki and Harada, Ryuhei and Saito, Saki and Funayama, Yukino and Ikeda, Kensuke and Mitsuzawa, Shio and Watanabe, Yasuaki and Shijo, Tomomi and Akiyama, Tetsuya and Takahashi, Toshiaki and Kanzaki, Makoto and Osana, Shion and Warita, Hitoshi and Aoki, Yoshitsugu and Ebihara, Satoru and Salvi, Mauro and Nagatomi, Ryoichi and Yasui, Akira and Miyake, Katsuya and Aoki, Masashi},
title = {A Novel Dysferlin‐Binding Kinase CK2α Promotes Plasma Membrane Repair in Dysferlinopathy},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {6},
doi = {10.1096/fj.202500773rrr}
}
EUVIMED